These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23911883)

  • 1. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.
    Peng H; Yuan X; Shi R; Wei X; Ren S; Yan C; Ding Y; Lin Y; Fan D; Yang M; Zhang Y; Xiong D
    Eur J Pharmacol; 2013 Oct; 718(1-3):459-68. PubMed ID: 23911883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.
    Cai Y; Lu J; Miao Z; Lin L; Ding J
    Cancer Biol Ther; 2007 Nov; 6(11):1794-9. PubMed ID: 18032928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R; Li W; Zhang X; Zhang Y; Peng H; Xie Y; Fan D; Liu R; Liu X; Xiong D
    Eur J Pharmacol; 2011 Nov; 669(1-3):38-44. PubMed ID: 21871878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
    Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J
    Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
    Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
    Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
    Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K
    Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species contribute to TRAIL receptors upregulation; the mechanism for PH II-7 augmenting TRAIL induced apoptosis in leukemia cells.
    Peng H; Yuan X; Luo S; Li F; Wei X; Ye Z; Xiong D
    Eur J Pharmacol; 2015 Jan; 746():344-52. PubMed ID: 25446561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.
    Hu Y; Cheng X; Li S; Zhou Y; Wang J; Cheng T; Yang M; Xiong D
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):789-98. PubMed ID: 24013575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
    Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM
    Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
    Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
    Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells.
    Li X; Zhao Y; Ji M; Liu SS; Cui M; Lou HX
    Chin Med J (Engl); 2011 Jul; 124(13):2038-44. PubMed ID: 22088467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of proteasome inhibitor bortezomib on a P-gp positive leukemia cell line K562/A02.
    Lü S; Chen Z; Yang J; Chen L; Zhou H; Xu X; Li J; Han F; Wang J
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e123-31. PubMed ID: 19254348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells.
    Meshkini A; Yazdanparast R
    Exp Toxicol Pathol; 2012 May; 64(4):357-65. PubMed ID: 21074392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species.
    Wang J; Liu L; Cen J; Ji B
    Chem Biol Interact; 2015 Sep; 239():139-45. PubMed ID: 26169035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligustrazine derivate DLJ14 reduces multidrug resistance of K562/A02 cells by modulating GSTπ activity.
    Song YN; Guo XL; Zheng BB; Liu XY; Dong X; Yu LG; Cheng YN
    Toxicol In Vitro; 2011 Jun; 25(4):937-43. PubMed ID: 21402141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.